Lah Soowhan, Wilson Emily L, Beesley Sarah, Sagy Iftach, Orme James, Novack Victor, Brown Samuel M
Center for Humanizing Critical Care, Intermountain Healthcare, Murray, UT, USA.
Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT, USA.
BMC Health Serv Res. 2018 Jan 9;18(1):12. doi: 10.1186/s12913-017-2801-3.
The Center for Medicare and Medicaid Services (CMS) and the Hospital Quality Alliance began collecting and reporting United States hospital performance in the treatment of pneumonia and heart failure in 2008. Whether the utilization of hospice might affect CMS-reported mortality and readmission rates is not known.
Hospice utilization (mean days on hospice per decedent) for 2012 from the Dartmouth Atlas (a project of the Dartmouth Institute that reports a variety of public health and policy-related statistics) was merged with hospital-level 30-day mortality and readmission rates for pneumonia and heart failure from CMS. The association between hospice use and outcomes was analyzed with multivariate quantile regression controlling for quality of care metrics, acute care bed availability, regional variability and other measures.
2196 hospitals reported data to both CMS and the Dartmouth Atlas in 2012. Higher rates of hospice utilization were associated with lower rates of 30-day mortality and readmission for pneumonia but not for heart failure. Higher quality of care was associated with lower rates of mortality for both pneumonia and heart failure. Greater acute care bed availability was associated with increased readmission rates for both conditions (p < 0.05 for all).
Higher rates of hospice utilization were associated with lower rates of 30-day mortality and readmission for pneumonia as reported by CMS. While causality is not established, it is possible that hospice referrals might directly affect CMS outcome metrics. Further clarification of the relationship between hospice referral patterns and publicly reported CMS outcomes appears warranted.
医疗保险和医疗补助服务中心(CMS)与医院质量联盟于2008年开始收集并报告美国医院在肺炎和心力衰竭治疗方面的表现。临终关怀的使用是否会影响CMS报告的死亡率和再入院率尚不清楚。
将达特茅斯地图集(达特茅斯研究所的一个项目,报告各种公共卫生和政策相关统计数据)中2012年的临终关怀利用率(每位死者接受临终关怀的平均天数)与CMS提供的医院层面的肺炎和心力衰竭30天死亡率及再入院率进行合并。采用多变量分位数回归分析临终关怀使用与结局之间的关联,并控制护理质量指标、急性护理床位可用性、区域差异及其他指标。
2012年有2196家医院向CMS和达特茅斯地图集报告了数据。较高的临终关怀利用率与较低的肺炎30天死亡率和再入院率相关,但与心力衰竭无关。较高的护理质量与肺炎和心力衰竭的较低死亡率相关。更多的急性护理床位可用性与这两种情况的再入院率增加相关(所有p值均<0.05)。
如CMS所报告,较高的临终关怀利用率与较低的肺炎30天死亡率和再入院率相关。虽然因果关系尚未确立,但临终关怀转诊可能直接影响CMS的结局指标。进一步阐明临终关怀转诊模式与CMS公开报告的结局之间的关系似乎很有必要。